1 completed, 1 terminated, 1 unknown. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow mFOLFIRI: new trials by email Literature Review of mFOLFIRI trials Research Report on mFOLFIRI
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intraperitoneal Oxaliplatin in Combo w IV mFOLFIRI for Peritoneal Carcinomatosis From Colorectal & Appendiceal Cancer Oxaliplatin, mFOLFIRI - Colorectal Cancer, Appendiceal Cancer | Phase 1 | Terminated | University of Utah | 1 | 2021-03-22 | 2021-09-27 |
| Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer Gemcitabine, nab-paclitaxel, FOLFIRINOX - Stage IV Pancreatic Cancer | Phase 1 / Phase 2 | Completed | Pancreatic Cancer Research Team | 60 | 2011-11-01 | 2016-08-18 |
| mFOLFIRI as the Second Line Chemotherapy for Advanced Esophageal Carcinoma After Failure of 1st Line Treatment of Paclitaxel/DDP : a Phase II Single Center Prospective Clinical Trial mFOLFIRI - Advanced Esophageal Carcinoma | Phase 2 | Unknown | Peking University | 50 | 2009-05-01 | 2010-01-07 |
Appendiceal Neoplasms (1) · Colorectal Neoplasms (1) · Pancreatic Neoplasms (1)
Pancreatic Cancer Research Team (1) · Peking University (1) · University of Utah (1)
United States (2) · China (1)
Laura Lambert, MD (1) · Ramesh K Ramanathan, MD (1)